DETAILS, FICTION AND SQUALENE

Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely designed TPD approaches. In this assessment, we focus on the two preclinical experiments and medical trials to supply a comprehensive summary of the protection and clinical usefulness of PROTACs and MGDs in hematologic malignancies over the